Divi's Laboratories Limited manufactures and sells generic active pharmaceutical ingredients (APIs) and intermediates, and nutraceutical ingredients in India, the United States, Asia, Europe, and internationally. It also undertakes custom synthesis of APIs and intermediates; and supplies a range of carotenoids, as well as markets vitamins to nutritional, pharma, food/beverage, and feed industries. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. The company was incorporated in 1990 and is headquartered in Hyderabad, India.
P/E ratio for Divi's Laboratories Limited (DIVISLAB.NS)
P/E ratio as of 2023: 59.20
According to Divi's Laboratories Limited's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 59.20. At the end of 2022 the company had a P/E ratio of 41.09.
P/E ratio history for Divi's Laboratories Limited from 2005 to 2023
PE ratio at the end of each year
| Year | P/E ratio |
|---|---|
| 2023 | 59.20 |
| 2022 | 41.09 |
| 2021 | 39.47 |
| 2020 | 48.47 |
| 2019 | 38.36 |
| 2018 | 33.82 |
| 2017 | 33.00 |
| 2016 | 15.62 |
| 2015 | 23.57 |
| 2014 | 27.83 |
| 2013 | 23.44 |
| 2012 | 22.02 |
| 2011 | 19.06 |
| 2010 | 20.82 |
| 2009 | 25.98 |
| 2008 | 14.67 |
| 2007 | 23.57 |
| 2006 | 21.21 |
| 2005 | 34.59 |